1 enrolling by invitation, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Enrolling by invitation 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Abela Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotics in COPD: Effects on Symptoms, Lung Function, and Inflammation Probiotic Capsule, placebo capsule - COPD, COPD (Chronic Obstructive Pulmonary Disease) | Not applicable | Enrolling by invitation | University Hospital of Split | 60 | 2026-03-08 | 2026-04-21 |
| Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury AbelaDrug200, mannitol - Severe Head Trauma | Phase 1 / Phase 2 | Unknown | Abela Pharmaceuticals, Inc. | 30 | 2010-10-01 | 2010-12-08 |
Brain Injuries, Traumatic (1) · Craniocerebral Trauma (1) · Dyspnea (1) · Head Injuries, Closed (1) · Pulmonary Disease, Chronic Obstructive (1)
Dietary Supplements (1) · Mannitol (1) · Probiotics (1)
Croatia (1) · United States (1)